Výsledky vyhledávání - "Meek, Inger L."

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Effect of metformin use on clinical outcomes and serum urate in gout patients with diabetes mellitus: a retrospective cohort study.

Autor: Veenstra, Frouwke, Verhoef, Lise M., Opdam, Merel, den Broeder, Alfons A., Kwok, Wing-Yee, Meek, Inger L., van den Ende, Cornelia H. M., Flendrie, Marcel, van Herwaarden, Noortje

Publikováno v: BMC Rheumatology; 5/31/2022, Vol. 6 Issue 1, p1-6, 6p

Zobrazit plný text záznamu

Akademický článek

Hyperuricaemia: a marker of increased cardiovascular risk in rheumatic patients: analysis of the ACT-CVD cohort.

Autor: Meek, Inger L.^1,2 i.meek@reuma.umcn.nl, Vonkeman, Harald E.¹ h.vonkeman@mst.nl, van de Laar, Mart A. F. J.¹ m.vandelaar@mst.nl

Publikováno v: BMC Musculoskeletal Disorders. 2014, Vol. 15 Issue 1, p1-16. 16p. 2 Charts, 2 Graphs.

Zobrazit plný text záznamu

Akademický článek

Cardiovascular case fatality in rheumatoid arthritis is decreasing; first prospective analysis of a current low disease activity rheumatoid arthritis cohort and review of the literature.

Autor: Meek, Inger L.¹ i.meek@reuma.umcn.nl, Vonkeman, Harald E.² h.vonkeman@mst.nl, van de Laar, Mart A. F. J.² m.vandelaar@mst.nl

Publikováno v: BMC Musculoskeletal Disorders. 2014, Vol. 15 Issue 1, p1-17. 17p. 3 Charts.

Zobrazit plný text záznamu

Stopping Tumor Necrosis Factor Inhibitor Treatment in Patients With Established Rheumatoid Arthritis in Remission or With Stable Low Disease Activity: A Pragmatic Randomized Multicenter Open-Label Controlled Trial

Autor: Moghadam, Marjan Ghiti, Vonkeman, Harald E., ten Klooster, Peter M., Tekstra, Janneke, van Schaardenburg, Dirkjan, Starmans-Kool, Mirian, Brouwer, Elisabeth, Bos, Reinhard, Lems, Willem F., Colin, Edgar M., Allaart, Cornelia F., Meek, Inger L., Landewe, Robert, Moens, Hein J. Bernelot, van Riel, Piet L. C. M., van de Laar, Mart A. F. J., Jansen, Tim L.

Publikováno v: Arthritis & Rheumatology, 68(8), 1810-1817. Wiley

Objective. Tumor necrosis factor inhibitor (TNFi) biologic agents are an effective treatment for rheumatoid arthritis (RA). It is unclear whether patients whose disease is in remission or who have stable low disease activity need to continue use of T

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::cf6379d8097779830a7553201e3cc363
https://research.rug.nl/en/publications/75ccda06-abe5-4648-a6c6-35c31c5a3440

Zobrazit plný text záznamu

Stopping Tumor Necrosis Factor Inhibitor Treatment in Patients With Established Rheumatoid Arthritis in Remission or With Stable Low Disease Activity: A Pragmatic Multicenter, Open‐Label Randomized Controlled Trial

Autor: Ghiti Moghadam, Marjan, Vonkeman, Harald E., ten Klooster, Peter M., Tekstra, Janneke, van Schaardenburg, Dirkjan, Starmans-Kool, Mirian, Brouwer, Elisabeth, Bos, Reinhard, Lems, Willem F., Colin, Edgar M., Allaart, Cornelia F., Meek, Inger L., Landewé, Robert, Bernelot Moens, Hein J., van Riel, Piet L. C. M., van de Laar, Mart A. F. J., Jansen, Tim L.

Publikováno v: Arthritis & rheumatology, 68(8), 1810-1817. Wiley
Arthritis & rheumatology (Hoboken, N.J.), 68(8), 1810-1817. John Wiley and Sons Ltd

OBJECTIVE: Tumor necrosis factor inhibitor (TNFi) biologic agents are an effective treatment for rheumatoid arthritis (RA). It is unclear whether patients whose disease is in remission or who have stable low disease activity need to continue use of T

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::057e5466e46dda61e7718ab15ad8635e
https://research.utwente.nl/en/publications/b11cb1cb-9319-4aaa-b027-786b72e3e25c

Zobrazit plný text záznamu

Autor: Lesuis, N., Piek, E., Demirel, Hatice, den Broeder, A.A., Hulscher, M.E.J.L., Meek, Inger L., van der Laan-Baalbergen, Nicole, van Vollenhoven, RF

Publikováno v: Arthritis Care & Research. John Wiley and Sons Inc.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::35453e238238bf515a6bd905a1ab4558
https://research.vumc.nl/en/publications/acf572d3-40b9-4a7a-8ae3-af26a314a758

Zobrazit plný text záznamu

Increased Serum Uric Acid: Consequence or Cause of Increased Cardiovascular Risk

Autor: Meek, Inger L., Vonkeman, Harald E., van de Laar, Mart A.F.J.

Publikováno v: ACR/ARHP Annual Meeting 2012

Background/Purpose: Reports on cardiovascular (CV) disease in hyperuricemia and gout show conflicting results. Some studies show hyperuricemia to be an independent risk factor for CV events and death, others find no such associations or only with gou

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::682397d0cb1691e2b67da9b97fb08596
https://research.utwente.nl/en/publications/increased-serum-uric-acid(1142d942-b409-4417-9bda-bd255e19d10d).html

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání